Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Accepts healthy volunteers Results available

Real World CCH Study in Adult Females With Cellulite

ClinicalTrials.gov ID: NCT04170296

Public ClinicalTrials.gov record NCT04170296. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 18, 2026, 8:23 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Real World, Multicenter, Open-Label, Multiple Dose Study to Assess the Effectiveness of, and Satisfaction With, CCH Treatment of Buttocks or Thigh Cellulite in Adult Females

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, open-label, multiple dose, 2 cohort, Phase 3b study to assess the safety and efficacy of CCH in adult women with mild or moderate edematous fibrosclerotic panniculopathy (EFP). Cohort 1 will include approximately 80 subjects with mild or moderate EFP in the posterolateral thighs and Cohort 2 will include approximately 70 subjects with mild or moderate EFP in the buttocks.

Study identification

NCT ID
NCT04170296
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
153 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 60 Years
Sex
Female
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 1, 2019 (Actual)
Primary completion
Oct 6, 2020 (Actual)
Completion
Jan 8, 2021 (Actual)
Last update posted
Feb 22, 2022

2019 – 2021

United States locations

U.S. sites
11
U.S. states
8
U.S. cities
11
Facility City State ZIP Site status
Endo Clinical Trial Site #2 Encino California 91436 —
Endo Clinical Trial Site #4 San Diego California 92121 —
Endo Clinical Trial Site #5 Solana Beach California 92075 —
Endo Clinical Trial Site #9 Westport Connecticut 00688 —
Endo Clinical Trial Site #1 Coral Gables Florida 33146 —
Endo Clinical Trial Site #10 Alpharetta Georgia 30005 —
Endo Clinical Trial Site #3 Chicago Illinois 60611 —
Endo Clinical Trial Site #11 Itasca Illinois 60143 —
Endo Clinical Trial Site #8 New Orleans Louisiana 70130 —
Endo Clinical Trial Site #6 New York New York 10021 —
Endo Clinical Trial Site #12 Nashville Tennessee 37215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04170296, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 22, 2022 · Synced Oct 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04170296 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →